Torre F - Search Results

1

Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to use.

Picciotto A, Campo N, Brizzolara R, Sinelli N, Torre F, Cipriani AG, Ponassi I, Varagona G, Grasso A, De Leo P, De Conca V, Mesiti S, Marenco G, Menardo G, Dodero M, Celle G. Picciotto A, et al. Among authors: torre f. Eur J Gastroenterol Hepatol. 1999 Jun;11(6):649-53. Eur J Gastroenterol Hepatol. 1999. PMID: 10418937

2

Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Puppo F, Torre F, Contini P, Ghio M, Brenci S, Brizzolara R, Sinelli N, Campo N, Indiveri F, Picciotto A. Puppo F, et al. Among authors: torre f. J Clin Immunol. 2000 Nov;20(6):486-90. doi: 10.1023/a:1026468001834. J Clin Immunol. 2000. PMID: 11202239 Clinical Trial.

3

Clearance kinetics of hepatitis C virus under different antiviral therapies.

Torre F, Giusto R, Grasso A, Brizzolara R, Campo N, Sinelli N, Balestra V, Picciotto A. Torre F, et al. J Med Virol. 2001 Aug;64(4):455-9. doi: 10.1002/jmv.1071. J Med Virol. 2001. PMID: 11468729 Clinical Trial.

4

Antiviral activity of amantadine in elderly patients with chronic hepatitis C.

Torre F, Campo N, Giusto R, Ansaldi F, Icardi GC, Picciotto A. Torre F, et al. Gerontology. 2001 Nov-Dec;47(6):330-3. doi: 10.1159/000052823. Gerontology. 2001. PMID: 11721147 Clinical Trial.

5

Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients.

Campo N, Sinelli N, Brizzolara R, Torre F, Gurreri G, Russo R, Saffioti S, Celle G, Picciotto A. Campo N, et al. Among authors: torre f. Nephron. 1999;82(1):17-21. doi: 10.1159/000045362. Nephron. 1999. PMID: 10224479

6

Amantadine: a different approach.

Torre F, Picciotto A. Torre F, et al. J Hepatol. 2002 May;36(5):705. doi: 10.1016/s0168-8278(02)00030-2. J Hepatol. 2002. PMID: 11983458 No abstract available.

7

A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy.

Giannini EG, Torre F, Basso M, Feasi M, Boni S, Grasso A, De Leo P, Dodi F, Marazzi MG, Azzola E, Bartolacci V, Percario G, Beltrame A, Borro P, Savarino V, Picciotto A; Ligurian Hepatitis B Virus Study Group. Giannini EG, et al. Among authors: torre f. J Clin Gastroenterol. 2009 Nov-Dec;43(10):1001-7. doi: 10.1097/MCG.0b013e31818e876f. J Clin Gastroenterol. 2009. PMID: 19318981

8

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.

Basso M, Giannini EG, Torre F, Blanchi S, Savarino V, Picciotto A. Basso M, et al. Among authors: torre f. Hepatology. 2009 May;49(5):1442-8. doi: 10.1002/hep.22810. Hepatology. 2009. PMID: 19350657

9

Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients.

Torre F, Giannini EG, Basso M, Fazio V, Savarino V, Picciotto A. Torre F, et al. J Gastrointestin Liver Dis. 2011 Mar;20(1):47-50. J Gastrointestin Liver Dis. 2011. PMID: 21451797 Free article.

10

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

Torre F, Rossol S, Pelli N, Basso M, Delfino A, Picciotto A. Torre F, et al. Clin Exp Immunol. 2004 Jun;136(3):507-12. doi: 10.1111/j.1365-2249.2004.02476.x. Clin Exp Immunol. 2004. PMID: 15147353 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters